您好, 访客   登录/注册

综合护理在胺碘酮治疗心衰合并心律失常患者中的应用价值

来源:用户上传      作者:

   【摘要】 目的:分析综合护理对行胺碘酮治疗的心衰并心律失常患者的应用价值。方法:选取2017年9月-2018年10月笔者所在医院行胺碘酮治疗的59例心衰并心律失常患者为研究对象,将其随机分为两组。对照组29例患者给予常规护理,观察组30例患者给予综合护理干预。比较两组患者护理满意度、不良反应发生情况及临床治疗指标(心率、血压)变化情况。结果:护理后观察组心率、血压均优于对照组,差异有统计学意义(P<0.05);观察组护理满意度高于对照组,差异有统计学意义(P<0.05),观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:对行胺碘酮治疗的心衰并心律失常者给予综合护理干预可提高治疗效果,降低不良反应发生率,提高患者满意度。
   【关键词】 心律失常; 综合护理; 胺碘酮; 心力衰竭
   doi:10.14033/j.cnki.cfmr.2019.15.039 文献标识码 B 文章编号 1674-6805(2019)15-00-03
   【Abstract】 Objective:To analyze the effect of comprehensive nursing in heart failure patients with arrhythmia underwent the treatment of Amiodarone.Method:A total of 59 heart failure patients with arrhythmia underwent the treatment of Amiodarone from September 2017 to October 2018 were selected.They were randomly divided into two groups.29 patients in the control group was treated with conventional nursing,while 30 patients in the observation group was treated with comprehensive nursing interventions.The nursing satisfaction,adverse reactions and clinical treatment index(heart rate,blood pressure)were compared between the two groups.Result:After nursing,heart rate and blood pressure in the observation group were better than those in the control group,the differences were statistically significant(P<0.05).The nursing satisfaction in the observation group was higher than that in the control group,the difference was statistically significant(P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Comprehensive nursing intervention for patients with heart failure and arrhythmia treated with Amiodarone can improve the therapeutic effect,reduce the incidence of adverse reactions,and improve patients’ satisfaction.
   【Key words】 Arrhythmia; Comprehensive nursing; Amiodarone; Heart failure
   心衰不仅是临床心脏疾病的终末期阶段,也是引发器质性心脏病患者死亡的重要原因之一,患者因心肌受损、结构变化,易出现呼吸困难、液体潴留等症状,且常常伴有心律失常并发症。临床认为两种疾病会相互影响,加重患者心肌損害,危及患者生命安全,胺碘酮是临床心律失常有效治疗药物,其用于心衰并心律失常治疗,能促进心率改善,提高患者生存质量[1-2]。但大量实践表明胺碘酮虽有良好治疗效用,然而受个体差异、用药不当等因素影响,患者治疗期间易出现不良反应,影响治疗效果。综合护理是目前临床较为新型的护理模式,其通过对患者心理、饮食等方面给予综合性护理,让患者更好配合治疗、减少不良反应发生,从而促进患者康复[3]。本文选取2017年9月-2018年10月笔者所在医院行胺碘酮治疗期间给予综合护理干预的30例患者进行研究,旨在为今后护理措施实施提供参考,现报道如下。
  1 资料与方法
  1.1 一般资料
   选取2017年9月-2018年10月笔者所在医院行胺碘酮治疗的59例心衰并心律失常患者为研究对象,纳入标准:经检查确诊;无合并其他严重器质性疾病、恶性肿瘤;无言语、精神障碍。排除标准:患者存在用药禁忌证;临床资料不完整;治疗期间自愿退出试验者。随机分为两组。对照组29例,男17例,女12例;年龄57~72岁,平均(64.1±2.0)岁;原发病:冠心病11例,高血压心脏病8例,风湿性心脏病6例,心肌炎4例。观察组30例,男18例,女12例;年龄56~73岁,平均(64.7±2.3)岁;原发病:冠心病11例,高血压心脏病9例,风湿性心脏病7例,心肌炎3例。两组患者基线资料比较,差异无统计学意义(P>0.05),有可比性。本研究经医院伦理委员会批准通过,所有患者及家属均签署知情同意书。
转载注明来源:https://www.xzbu.com/6/view-14964538.htm